Scroll to top
© 2020, Startuprecipe theme by Rssow

PR Newswire and AAP further strengthen partnership to expand the Australia Distribution Network

2022/12/12

PR Newswire and AAP further strengthen partnership to expand the Australia Distribution Network

SYDNEY, Dec. 12, 2022 /PRNewswire/ — Cision PR Newswire and Australian Associated Press (AAP) are happy to announce a strengthened partnership that expands the distribution reach in Australia. PR Newswire has been working closely with AAP over the past 20...

2022/12/09

Epulze Set to lead 2023 Southeast Asia Dota 2 Pro Circuit With EBN

The pair is tasked by Valve to champion its esports scene in the region KUALA LUMPUR, Malaysia, Dec. 9, 2022 /PRNewswire/ — Epulze, a global esports entertainment and tournament platform provider join force with leading Southeast Asian esports marketing agency Esport...

2022/12/09

THE PIAGGIO GROUP AND FOTON MOTOR GROUP SIGN A GENERAL AGREEMENT FOR JOINT DEVELOPMENT OF A NEW ELECTRICALLY POWERED LIGHT COMMERCIAL VEHICLE

BEIJING, Dec. 9, 2022 /PRNewswire/ — The Chairman and CEO of Piaggio & C. S.p.A. (PIA.MI), Roberto Colaninno, and the Vice General Manager of Foton Motor Group, Wang Shuhai, signed a preliminary agreement in Mantua for the development of a new range of four-wheel electric light commercial vehicles. The...

2022/12/09

Viettel and UTL Group Sign Strategic Agreement on Comprehensive R&D and Deployment of 5G Network Infrastructure in India

Comprehensive cooperation on Research, Development and Manufacturing Make-in-India products in all layers of 5G Telecom Network Infrastructure. HANOI, Vietnam, Dec. 9, 2022 /PRNewswire/ — Viettel Group displayed new radars, drones and surveillance systems at The Vietnam International Defense Expo 2022, the first...

2022/12/09

CGTN: What has China done in its nearly 3 years of COVID-19 fight?

BEIJING, Dec. 9, 2022 /PRNewswire/ — It’s been nearly three years since China launched the fight against COVID-19. During that time, China’s relentless efforts protected its people and provided valuable experiences for the world. The efforts also bought precious time...

2022/12/09

CGTN: China, Saudi Arabia to forge all-round, high-level cooperation pattern

BEIJING, Dec. 9, 2022 /PRNewswire/ — China–Saudi Arabia strategic mutual trust has been strengthened, and the bilateral practical cooperation in various fields has yielded fruitful results since the establishment of diplomatic ties 32 years ago, Chinese President Xi Jinping said...

2022/12/09

CGTN: Poll: 85% of respondents laud China's concept of shared future

BEIJING, Dec. 9, 2022 /PRNewswire/ — As many as 85 percent of respondents in a global survey have praised the concept of "a community with a shared future for mankind" while 94.2 percent of them appreciated China-proposed values of "peace, development,...

2022/12/09

LABUAN FSA AWARDED THE "BRANDLAUREATE E-BRANDING BESTBRANDS AWARD FOR FINTECH ISLAMIC FINANCIAL SERVICES"

KUALA LUMPUR, Malaysia, Dec. 9, 2022 /PRNewswire/ — Labuan Financial Services Authority (Labuan FSA) received an accolade the BrandLaureate Brand of the Year Awards 2022 when it was awarded with "The BrandLaureate e-Branding BestBrands Award for Fintech Islamic Financial Services". At...

2022/12/09

A Successful Conclusion of CamTech Summit Powered by Prudential Cambodia 2022

PHNOM PENH, Cambodia , Dec. 9, 2022 /PRNewswire/ — Cambodian Association of Finance and Technology (CAFT), the National Bank of Cambodia (NBC), The Association of Banks in Cambodia (ABC) and Cambodia Microfinance Association (CMA) with Prudential Cambodia as its Title Sponsor successfully...

2022/12/09

The world's first VR game-based variety show MEMOON PLAYER employs six times more engineers than show directors

BEIJING, Dec. 9, 2022 /PRNewswire/ — MEMOON PLAYER, a virtual reality (VR) game-based variety show is currently being aired in China on online video platform IQIYI. The six resident players, Wowkie Da, Victor Qin, Lil Ghost, Jam Hsiao, Rainbow Xu and...

2022/12/09

Antengene Announces HREC Approval in Australia for the Phase I Trial of ATG-022 (Claudin 18.2 ADC) in Patients with Advanced or Metastatic Solid Tumors

Discovered in-house by Antengene’s R&D team, ATG-022 is an antibody-drug-conjugate targeting the Tumor Associated Antigen (TAA) Claudin 18.2 The Phase I trial is designed to evaluate the safety, pharmacology, and preliminary efficacy of ATG-022 as a monotherapy in patients with...

2022/12/09

GWM, Sponsor of BWF World Tour Finals 2022, Advocates A Clean and Intelligent Lifestyle

BAODING, China, Dec. 9, 2022 /PRNewswire/ — The HSBC BWF World Tour Finals 2022 took place in Bangkok, Thailand on December 7. As an official partner, GWM provides green commuting services for athletes and staff from different countries with its new...

2022/12/08

CGTN: Xi visits the Middle East: What to be expected

BEIJING, Dec. 8, 2022 /PRNewswire/ — Chinese President Xi Jinping will attend the first China-Arab States Summit and the China-Gulf Cooperation Council (GCC) Summit in Riyadh, Saudi Arabia, and pay a state visit to the country from December 7 to...

2022/12/08

JinkoSolar Signed a Strategic Distribution Agreement with Blue Sun Group for Future Cooperation

SUNSHINE COAST, Australia, Dec. 8, 2022 /PRNewswire/ — On 29th of November, JinkoSolar, one of the largest and most innovative solar module manufacturers in the world, announced it has signed a strategic distribution agreement with Blue Sun Group, a well-known wholesaler...

2022/12/08

EDM Council Benchmark Report Details Strategic Rise of Chief Data Officers

Biennial study uncovers expanding role of the CDO and wider establishment of data management across industries worldwide NEW YORK, Dec. 8, 2022 /PRNewswire/ — EDM Council, the cross-industry trade association for data management, has released its 2023 Global Data Management Benchmark...

2022/12/08

LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA

First Orphan Drug Designation (ODD) in the field of microbiome-based treatment for metabolic diseases SEOUL, South Korea, Dec. 8, 2022 /PRNewswire/ — LB-P8, a novel drug being developed by LISCure Biosciences, Inc. (LISCure) as a treatment for Primary Sclerosing Cholangitis...

Access to the latest Korean startup news and startup database for free

sign up for Startup Recipe newsletter